Search
Sumario de resultados
TIpos de contenido
Fecha
-
NewJoan Puig: "In inorganic growth in Europe, cultural difference is one of the most importan...
Joan Puig, a graduate in Pharmacy and in Business Administration and Management, and with a General Management Programme (PDG) from IESE, has an extensive background in the field of analytical and
-
NewAdigital, AESEMI and AseBio drive a joint proposal to position Spain at the forefront of d...
The aim of this document is to promote a specific regulatory framework that recognises these technologies as a strategic sector for the country’s technological autonomy and competitiveness, as well as
-
Press releaseAdigital, AESEMI and AseBio drive a joint proposal to position Spain at the forefront of d...
The three national associations have submitted a joint document to the Ministry of Science, Innovation and Universities containing 13 concrete proposals to respond to the public consultation and guide
-
-
NewBiotechnology, key to curbing antimicrobial resistance and strengthening European health s...
In 2021, antimicrobial resistance was involved in at least 4.7 million deaths worldwide, with 35,000 annual deaths in Europe and nearly 4,000 in Spain.
-
Press release
Biotechnology, key to curbing antimicrobial resistance and strengthening European health s...
In 2021, antimicrobial resistance was involved in at least 4.7 million deaths worldwide, including 35,000 annual deaths in Europe and around 4,000 in Spain. The WHO warns of a sustained increase in
-
EventBIOTRINITY
-
-
EventRESI JPM
-
-
CompanyBRAND COMUNICACION
-
-
CompanyNEURAL OMEGA
-
CompanyBEPHARMA INSTITUTE
-
Press release
A 20% increase in survival through early diagnosis: biotechnology accelerates change in th...
Low-dose CT screening can significantly reduce mortality and increase patient survival by around 20%, according to international scientific evidence Biotechnology is revolutionising lung cancer
-
NewChronic Inflammation: A Key Factor in the Threat to Healthy Aging and Healthy Living
Recent research links persistent inflammatory status to metabolic, neurodegenerative and cardiovascular pathologies.
-
CompanyVIROFEND THERAPEUTICS S.L.
-
CompanyTETRANEURON
-
CompanyLOEC INNOVATIONS, S.L.
-
NewORYZON reports financial results and corporate update for quarter ended September 30, 2025
The net result as of September 30, 2025 improved by $1.1M compared to September 2024, following termination of a Convertible Bonds financing facility with Nice&Green
-
NewAseBio participates in the public consultation of the upcoming Biotech Act with proposals ...
Harmonizing regulation, improving access to funding and talent, advancing biomanufacturing and artificial intelligence, and strengthening Europe’s strategic autonomy to build a more competitive
